BioMed Research International

Helicobacter pylori Infection


Status
Published

Lead Editor

1National Yang-Ming University, Kaohsiung, Taiwan

2Oita University, Oita, Japan

3University of Malaya Medical Center, Kuala Lumpur, Malaysia

4Azienda Ospedaliero-Universitaria, Parma, Italy

5Kaohsiung Medical University, Kaohsiung, Taiwan

6Chulalongkorn University, Bangkok, Thailand


Helicobacter pylori Infection

Description

Helicobacter pylori ( H. pylori) colonizes the gastric mucosa of more than 50% of the human population. It is the major etiological agent of chronic gastritis, peptic ulcer, gastric mucosa-associated lymphoid tissue lymphoma, and gastric adenocarcinoma. The concomitance of particular genotypes of both pathogen and host may lead to the development of serious gastroduodenal diseases.

With the rising prevalence of antimicrobial resistance, the treatment success of standard triple therapy has recently declined to unacceptable levels in most countries. Several strategies including sequential, concomitant, and hybrid therapies are therefore proposed to increase the eradication rate of first-line treatment for H. pylori infection. Since the best first-line eradication regimen with highest eradication rate and low adverse effects remains unclear and the exact route of transmission is still not exactly known, H. pylori infection continues to be a big challenge to all gastroenterologists 30 years after its discovery.

We invite investigators to contribute original research articles as well as review articles focusing on recent advances in the virulence factors of H. pylori, mechanism of H. pylori-induced gastric inflammation and carcinogenesis, promising first-line and rescue therapies, and vaccinating against H. pylori infection.

Potential topics include, but are not limited to:

  • Epidemiology of H. pylori infection and public health implications
  • Molecular cross-talk between H. pylori and human gastric mucosa
  • Pathogenesis of H. pylori infection
  • Natural outcome of H. pylori infection in asymptomatic children
  • Extragastrointestinal manifestations of H. pylori infection
  • Recent advances in the diagnosis of H. pylori infection
  • Emerging first-line anti- H. pylori therapy
  • Present status and future prospects of rescue regimens for H. pylori infection
  • Vaccinating against H. pylori

Articles

  • Special Issue
  • - Volume 2015
  • - Article ID 278308
  • - Editorial

Helicobacter pylori Infection

Ping-I Hsu | Yoshio Yamaoka | ... | Varocha Mahachai
  • Special Issue
  • - Volume 2015
  • - Article ID 914791
  • - Review Article

Biofilm Formation by Helicobacter pylori and Its Involvement for Antibiotic Resistance

Hideo Yonezawa | Takako Osaki | Shigeru Kamiya
  • Special Issue
  • - Volume 2015
  • - Article ID 623732
  • - Clinical Study

Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade “A” Success Rate for First-Line Helicobacter pylori Eradication

Wei-Chen Tai | Chih-Ming Liang | ... | Seng-Kee Chuah
  • Special Issue
  • - Volume 2015
  • - Article ID 808505
  • - Research Article

Correlation between Gastric Mucosal Morphologic Patterns and Histopathological Severity of Helicobacter pylori Associated Gastritis Using Conventional Narrow Band Imaging Gastroscopy

Taweesak Tongtawee | Soraya Kaewpitoon | ... | Likit Matrakool
  • Special Issue
  • - Volume 2015
  • - Article ID 830813
  • - Research Article

The Prevalence of Helicobacter pylori Virulence Factors in Bhutan, Vietnam, and Myanmar Is Related to Gastric Cancer Incidence

Tran Thi Huyen Trang | Seiji Shiota | ... | Yoshio Yamaoka
  • Special Issue
  • - Volume 2015
  • - Article ID 639521
  • - Research Article

Helicobacteraceae in Bulk Tank Milk of Dairy Herds from Northern Italy

Valentina Bianchini | Camilla Recordati | ... | Mario Luini
  • Special Issue
  • - Volume 2015
  • - Article ID 163960
  • - Clinical Study

Comparison of Second-Line Quadruple Therapies with or without Bismuth for Helicobacter pylori Infection

Guang-Hong Jheng | I-Chen Wu | ... | Ping-I Hsu
  • Special Issue
  • - Volume 2014
  • - Article ID 693567
  • - Research Article

Comparison of Proton Pump Inhibitor and Histamine-2 Receptor Antagonist in the Prevention of Recurrent Peptic Ulcers/Erosions in Long-Term Low-Dose Aspirin Users: A Retrospective Cohort Study

Wen-Chi Chen | Yun-Da Li | ... | Kwok-Hung Lai
  • Special Issue
  • - Volume 2014
  • - Article ID 151543
  • - Review Article

Quinolone-Containing Therapies in the Eradication of Helicobacter pylori

Seng-Kee Chuah | Wei-Chen Tai | ... | Tsung-Hui Hu
  • Special Issue
  • - Volume 2014
  • - Article ID 158520
  • - Clinical Study

Levofloxacin-Amoxicillin/Clavulanate-Rabeprazole versus a Standard Seven-Day Triple Therapy for Eradication of Helicobacter pylori Infection

Ming-Cheh Chen | Wei-Yi Lei | ... | Chi-Tan Hu
BioMed Research International
 Journal metrics
Acceptance rate31%
Submission to final decision67 days
Acceptance to publication30 days
CiteScore3.600
Impact Factor2.276
 Submit